Shares of Metlife Inc (NYSE:MET) have earned an average rating of “Hold” from the twenty-two ratings firms that are presently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, ten have issued a hold rating, eight have issued a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $57.75.

A number of research firms have recently commented on MET. Royal Bank of Canada restated an “outperform” rating and issued a $60.00 price objective (up from $56.00) on shares of Metlife in a report on Friday, November 3rd. Morgan Stanley raised their price objective on Metlife from $55.00 to $56.00 and gave the stock an “equal weight” rating in a report on Friday, November 3rd. Argus raised their price objective on Metlife from $55.00 to $60.00 and gave the stock a “buy” rating in a report on Monday, November 6th. Zacks Investment Research upgraded Metlife from a “strong sell” rating to a “hold” rating in a report on Monday, October 9th. Finally, FBR & Co downgraded Metlife from a “buy” rating to a “neutral” rating and dropped their target price for the company from $53.00 to $52.00 in a report on Tuesday, October 10th.

In other Metlife news, insider Christopher G. Townsend sold 55,712 shares of Metlife stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the sale, the insider now directly owns 25,181 shares in the company, valued at approximately $1,367,076.49. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Christopher G. Townsend sold 82,731 shares of Metlife stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $54.60, for a total value of $4,517,112.60. Following the sale, the insider now owns 49,660 shares in the company, valued at $2,711,436. The disclosure for this sale can be found here. Company insiders own 0.32% of the company’s stock.

A number of hedge funds have recently bought and sold shares of MET. Epoch Investment Partners Inc. increased its holdings in Metlife by 208.5% during the 3rd quarter. Epoch Investment Partners Inc. now owns 10,291,110 shares of the financial services provider’s stock worth $534,623,000 after purchasing an additional 6,954,917 shares during the last quarter. Prudential Financial Inc. increased its holdings in Metlife by 71.4% during the 2nd quarter. Prudential Financial Inc. now owns 3,672,729 shares of the financial services provider’s stock worth $201,778,000 after purchasing an additional 1,529,570 shares during the last quarter. BlackRock Inc. increased its holdings in Metlife by 2.2% during the 2nd quarter. BlackRock Inc. now owns 69,957,359 shares of the financial services provider’s stock worth $3,843,457,000 after purchasing an additional 1,481,489 shares during the last quarter. Arrowstreet Capital Limited Partnership purchased a new stake in Metlife during the 2nd quarter worth approximately $76,823,000. Finally, Vanguard Group Inc. increased its holdings in Metlife by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 66,723,143 shares of the financial services provider’s stock worth $3,665,769,000 after purchasing an additional 1,358,523 shares during the last quarter. Institutional investors own 76.24% of the company’s stock.

Metlife (NYSE MET) traded down $0.16 during trading on Wednesday, hitting $53.33. The stock had a trading volume of 5,480,400 shares, compared to its average volume of 4,790,000. The stock has a market cap of $56,120.00, a P/E ratio of 115.93, a price-to-earnings-growth ratio of 1.21 and a beta of 1.49. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.31. Metlife has a 52 week low of $44.43 and a 52 week high of $55.91.

Metlife (NYSE:MET) last released its quarterly earnings data on Wednesday, November 1st. The financial services provider reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.19. The company had revenue of $16.10 billion for the quarter, compared to the consensus estimate of $15.47 billion. Metlife had a positive return on equity of 8.81% and a negative net margin of 0.75%. The company’s quarterly revenue was up 1.7% compared to the same quarter last year. During the same period last year, the business posted $1.28 EPS. analysts expect that Metlife will post 4.4 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 13th. Investors of record on Monday, February 5th will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, February 2nd. This represents a $1.60 annualized dividend and a dividend yield of 3.00%. Metlife’s payout ratio is currently 347.83%.

COPYRIGHT VIOLATION WARNING: This article was reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this article on another domain, it was copied illegally and reposted in violation of international copyright and trademark law. The correct version of this article can be accessed at https://theolympiareport.com/2018/01/14/brokerages-set-metlife-inc-met-pt-at-57-75.html.

Metlife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Analyst Recommendations for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.